Why AI is the future of clinical trials

Name: Why AI is the future of clinical trials
Uploaded: 2024-08-16T05:49:45.821Z
Duration: 358.73

0:00

Play

Backward 10 seconds

Forward 10 seconds

Mute

0:00

Playback speed

Captions

Enter Fullscreen

https://cdn.streamly.video/From_Lab_to_Market_Stories_of_Biotech_5_b7ba506805.png

PREVIEW

Biotech Clinical trials AI & ML

Saurabh JainCEO at TrialKey

Saurabh Jain is the CEO of TrialKey, a pioneering company at the forefront of using artificial intelligence to revolutionize clinical trials.

With a deep expertise in both technology and healthcare, Saurabh has been instrumental in developing AI-driven solutions that enhance the accuracy and efficiency of clinical trial design.

Making psychedelic therapy accessible and affordable Dr. Prash Puspanathan

Driving innovation in biotech Dr. Nina Webster

How to invest with purpose and profit in the biotech industry Emerald Scofield

Navigating the pathway to success in biotech Rebecca McQualter

The key to a successful capital raise & non-dilutive funding James Graham

Navigating the pathway to biotech success Megan Baldwin

Show more content

Description

In this exclusive interview on Streamly, we sit down with Saurabh Jain, CEO of TrialKey, at the BioConnection Conference to explore the future of clinical trials and how AI is revolutionizing the landscape.

Saurabh shares groundbreaking insights on how TrialKey uses AI to predict clinical trial outcomes with 90% accuracy, optimizing trial designs, patient numbers, and endpoints.

Don't miss this thought-provoking conversation on how AI is shaping the future of healthcare and clinical research.

Table Of Contents

How AI is transforming clinical trials

Real-world applications and success stories

Challenges and adoption of AI in clinical trials

04:59 The Future of Clinical Trials

The future of clinical trials

Your cart